Formation of ring-D-hydroxylated estrogens from C-19 precursors administered to the fetus in utero.
D015068:17-Ketosteroids / Q000378:metabolism*; D000731:Androstanes / Q000378:metabolism*; D001805:Blood Transfusion, Intrauterine; D002247:Carbon Isotopes; D002845:Chromatography; D002854:Chromatography, Paper; D003460:Crystallization; D003687:Dehydroepiandrosterone / Q000378:metabolism*; D004899:Erythroblastosis, Fetal / Q000378:metabolism*; D004962:Estranes / Q000652:urine; D004964:Estriol / Q000652:urine; D004967:Estrogens / Q000652:urine*; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013261:Sterols / Q000652:urine; D013431:Sulfates; D014316:Tritium
D015068:17-Ketosteroids; D000731:Androstanes; D002247:Carbon Isotopes; D004962:Estranes; D004967:Estrogens; D013261:Sterols; D013431:Sulfates; D014316:Tritium; D003687:Dehydroepiandrosterone; D004964:Estriol